Literature DB >> 12377860

Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.

Hon-Kan Yip1, Mien-Cheng Chen, Hsueh-Wen Chang, Chi-Ling Hang, Yuan-Kai Hsieh, Chih-Yuan Fang, Chiung-Jen Wu.   

Abstract

BACKGROUND: Growing evidence suggests that no-reflow reperfusion after direct percutaneous coronary intervention (d-PCI) is associated with an unfavorable clinical outcome. The purpose of this study was to evaluate whether prerevascularization angiographic morphologic features of infarct-related arteries (IRAs) and timely reperfusion could convey information on slow-flow (Thrombolysis In Myocardial Infarction [TIMI] 2 flow) or no-reflow (TIMI grade < or = 1 flow) reperfusion after d-PCI. METHODS AND
RESULTS: Between May 1993 and September 2000, d-PCI was performed in 794 consecutive patients with acute myocardial infarction. Coronary blood flow failed to normalize in 120 patients (15.1%). The incidence of failure to achieve TIMI 3 flow in the IRAs was significantly higher in patients with vs those without the following distinctive prerevascularization angiographic morphologic features: cutoff pattern of occlusion in the IRA (52.4% vs 10.3%, p < 0.001), accumulated thrombus (> 5 mm) proximal to the occlusion (37.5% vs 3.4%, p < 0.001), presence of floating thrombus (66.7% vs 12.7%, p < 0.001), persistent dye stasis distal to the obstruction (51.9% vs 13.8%, p < 0.001), reference lumen diameter (RLD) of the IRA > or = 4 mm (46.3% vs 9.6%, p < 0.001), and incomplete obstruction with presence of accumulated thrombus more than three times the RLD of the IRA (51.7% vs 3.9, p < 0.0001). Each of these six angiographic morphologic features indicated "high-burden thrombus formation." Multiple stepwise logistic regression analysis demonstrated that each of six angiographic morphologic features was an independent predictor of combined slow-flow and no-reflow phenomenon in the IRAs after d-PCI (p < 0.05). In contrast, early reperfusion time (< 240 min, p = 0.0017), prerevascularization TIMI flow grade > or = 2 (p = 0.0006), and the taper pattern of occlusion in the IRA (p = 0.0284) were independent predictors of freedom from slow-flow or no-reflow phenomenon in the IRAs after d-PCI. The 30-day overall mortality was 8.7% (69 of 794 patients). The 30-day mortality was significantly higher in patients with combined slow-flow and no-reflow phenomenon than in patients with normal coronary blood flow after d-PCI (27.5% vs 5.3%, p < 0.001).
CONCLUSIONS: Early reperfusion reduces the incidence of slow-flow or no-reflow phenomenon in the IRA and overall 30-day mortality. The specific angiographic morphologic features in the IRAs can be used as a simple and efficacious method to predict slow-flow or no-reflow phenomenon. These findings provide apparently clinically useful information for the selection of patients who are potential candidates for subsequent prepercutaneous coronary intervention adjunctive therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12377860     DOI: 10.1378/chest.122.4.1322

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  62 in total

Review 1.  Thrombectomy during primary angioplasty: methods, devices, and clinical trial data.

Authors:  Giuseppe De Luca; Monica Verdoia; Ettore Cassetti
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

2.  Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.

Authors:  Li Dong-bao; Hua Qi; Liu Zhi; Wang Shan; Jin Wei-ying
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

3.  Arteriographic demonstration of slow antegrade opacification distal to a cerebrovascular thromboembolic occlusion site as a favorable indicator for intra-arterial thrombolysis.

Authors:  G A Christoforidis; Y Mohammad; B Avutu; A Tejada; A P Slivka
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

Review 4.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

5.  Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction.

Authors:  Yung-Lung Chen; Cheuk-Kwan Sun; Tzu-Hsien Tsai; Li-Teh Chang; Steve Leu; Yen-Yi Zhen; Jiunn-Jye Sheu; Sarah Chua; Kuo-Ho Yeh; Hung-I Lu; Hsueh-Wen Chang; Fan-Yen Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

6.  The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction.

Authors:  Ayhan Erkol; Vecih Oduncu; Burak Turan; Alev Kılıçgedik; Dicle Sırma; Gökhan Gözübüyük; Can Yücel Karabay; Ahmet Guler; Cihan Dündar; Kürşat Tigen; Selçuk Pala; Cevat Kırma
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

7.  Determinants of survival and favorable neurologic outcomes in ischemic heart disease treated by veno-arterial extracorporeal membrane oxygenation.

Authors:  Keisuke Yonezu; Kenichi Sakakura; Yusuke Watanabe; Yousuke Taniguchi; Kei Yamamoto; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2017-08-03       Impact factor: 2.037

8.  Minimalist immediate mechanical intervention in acute ST-segment elevation myocardial infarction: is it time to redefine targets?

Authors:  Philip Francis Dingli; Javier Escaned
Journal:  Cardiovasc Diagn Ther       Date:  2017-02

9.  Fine-tuning treatment for patients with ST-elevation myocardial infarction.

Authors:  Feng Qian; Edward L Hannan
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

10.  TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction.

Authors:  Juergen Kammler; Alexander Kypta; Robert Hofmann; Klaus Kerschner; Michael Grund; Kurt Sihorsch; Clemens Steinwender; Thomas Lambert; Wolfram Helml; Franz Leisch
Journal:  Clin Res Cardiol       Date:  2008-10-30       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.